Baxter International BAX Pharmaceuticals — Other segment items
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Baxter International in its filing.
Tagged under the XBRL concept us-gaap:OtherExpenses.
The official record: Baxter International’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Baxter International's pharmaceuticals — other segment items.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Baxter International's pharmaceuticals — other segment items?
- Baxter International (BAX) reported pharmaceuticals — other segment items of -$7M in Q1 2026.
- How has Baxter International's pharmaceuticals — other segment items changed year-over-year?
- Baxter International's pharmaceuticals — other segment items decreased by 0.0% year-over-year, from -$7M to -$7M.
- What does pharmaceuticals — other segment items mean?
- Miscellaneous income or expense items unique to the Pharmaceuticals segment that are not part of core operations.
- How do you interpret pharmaceuticals — other segment items?
- Large negative values may indicate one-time restructuring or litigation costs, while positive values may indicate one-time gains.
- How does pharmaceuticals — other segment items compare across companies?
- Varies widely by company; used to isolate core operating performance from noise.